Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 95

    2.

    Prevalence and correlates of hepatitis C infection among users of North America's first medically supervised safer injection facility.

    Wood E, Kerr T, Stoltz J, Qui Z, Zhang R, Montaner JS, Tyndall MW.

    Public Health. 2005 Dec;119(12):1111-5. Epub 2005 Oct 7.

    PMID:
    16214189
    [PubMed - indexed for MEDLINE]
    3.

    Use of North America's first medically supervised safer injecting facility among HIV-positive injection drug users.

    Reddon H, Wood E, Tyndall M, Lai C, Hogg R, Montaner J, Kerr T.

    AIDS Educ Prev. 2011 Oct;23(5):412-22.

    PMID:
    22010805
    [PubMed - indexed for MEDLINE]
    4.

    Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study.

    Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T.

    BMC Public Health. 2008 Dec 9;8:405.

    PMID:
    19068133
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility.

    Milloy MJ, Kerr T, Mathias R, Zhang R, Montaner JS, Tyndall M, Wood E.

    Am J Drug Alcohol Abuse. 2008;34(4):499-509.

    PMID:
    18584579
    [PubMed - indexed for MEDLINE]
    6.

    Police and public health partnerships: evidence from the evaluation of Vancouver's supervised injection facility.

    DeBeck K, Wood E, Zhang R, Tyndall M, Montaner J, Kerr T.

    Subst Abuse Treat Prev Policy. 2008 May 7;3:11.

    PMID:
    18462491
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility.

    Wood RA, Wood E, Lai C, Tyndall MW, Montaner JS, Kerr T.

    Int J Drug Policy. 2008 Jun;19(3):183-8. Epub 2008 Mar 26.

    PMID:
    18367389
    [PubMed - indexed for MEDLINE]
    8.

    Attendance, drug use patterns, and referrals made from North America's first supervised injection facility.

    Tyndall MW, Kerr T, Zhang R, King E, Montaner JG, Wood E.

    Drug Alcohol Depend. 2006 Jul 27;83(3):193-8. Epub 2005 Dec 13.

    PMID:
    16356659
    [PubMed - indexed for MEDLINE]
    9.

    Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?

    Wood E, Tyndall MW, Spittal PM, Li K, Kerr T, Hogg RS, Montaner JS, O'Shaughnessy MV, Schechter MT.

    CMAJ. 2001 Aug 21;165(4):405-10.

    PMID:
    11531048
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users.

    Wood E, Kerr T, Spittal PM, Li K, Small W, Tyndall MW, Hogg RS, O'Shaughnessy MV, Schechter MT.

    J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):2-8.

    PMID:
    12514408
    [PubMed - indexed for MEDLINE]
    11.

    Condom use among injection drug users accessing a supervised injecting facility.

    Marshall BD, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T.

    Sex Transm Infect. 2009 Apr;85(2):121-6. Epub 2008 Sep 23.

    PMID:
    18812391
    [PubMed - indexed for MEDLINE]
    12.

    Do supervised injecting facilities attract higher-risk injection drug users?

    Wood E, Tyndall MW, Li K, Lloyd-Smith E, Small W, Montaner JS, Kerr T.

    Am J Prev Med. 2005 Aug;29(2):126-30.

    PMID:
    16005809
    [PubMed - indexed for MEDLINE]
    13.

    Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.

    Spittal PM, Craib KJ, Wood E, Laliberté N, Li K, Tyndall MW, O'Shaughnessy MV, Schechter MT.

    CMAJ. 2002 Apr 2;166(7):894-9.

    PMID:
    11949985
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    Factors associated with sex trade involvement among male participants in a prospective study of injection drug users.

    Kuyper LM, Lampinen TM, Li K, Spittal PM, Hogg RS, Schechter MT, Wood E.

    Sex Transm Infect. 2004 Dec;80(6):531-5.

    PMID:
    15572630
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.

    Petrar S, Kerr T, Tyndall MW, Zhang R, Montaner JS, Wood E.

    Addict Behav. 2007 May;32(5):1088-93. Epub 2006 Aug 22.

    PMID:
    16930849
    [PubMed - indexed for MEDLINE]
    17.

    An external evaluation of a peer-run "unsanctioned" syringe exchange program.

    Wood E, Kerr T, Spittal PM, Small W, Tyndall MW, O'Shaughnessy MV, Schechter MT.

    J Urban Health. 2003 Sep;80(3):455-64.

    PMID:
    12930883
    [PubMed - indexed for MEDLINE]
    18.

    The Cedar project: prevalence and correlates of HIV infection among young Aboriginal people who use drugs in two Canadian cities.

    Spittal PM, Craib KJ, Teegee M, Baylis C, Christian WM, Moniruzzaman AK, Schechter MT; Cedar Project Partnership.

    Int J Circumpolar Health. 2007 Jun;66(3):226-40.

    PMID:
    17655063
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    Requiring help injecting independently predicts incident HIV infection among injection drug users.

    O'Connell JM, Kerr T, Li K, Tyndall MW, Hogg RS, Montaner JS, Wood E.

    J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):83-8.

    PMID:
    16123687
    [PubMed - indexed for MEDLINE]
    20.

    Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside.

    Kerr T, Wood E, Small D, Palepu A, Tyndall MW.

    CMAJ. 2003 Oct 14;169(8):759-63.

    PMID:
    14557313
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk